Luigi Rovati & family

$1.92B

as of 02/20/20

Luigi Rovati founded specialty drug maker Rottapharm; it started as an independent research lab in 1961.

He sold Rottapharm to Swedish drugmaker Meda in 2014 for $3.1 billion in cash and stock.

In 2016, Meda was acquired by U.S. pharmaceutical firm Mylan for $7.2 billion in cash and stock, and Rovati now owns a small stake in Mylan.

Rovati is no longer involved with the company he founded.

Italy

pharmaceuticals

07/22/28

self-made

32K

29K

19K

0.038%

0.008%